Invention Grant
- Patent Title: Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof
-
Application No.: US18339362Application Date: 2023-06-22
-
Publication No.: US12071443B2Publication Date: 2024-08-27
- Inventor: Xiao Ding , Liena Qin , Feng Ren , Jianyu Xu
- Applicant: Insilico Medicine IP Limited
- Applicant Address: HK Hong Kong
- Assignee: INSILICO MEDICINE IP LIMITED
- Current Assignee: INSILICO MEDICINE IP LIMITED
- Current Assignee Address: HK Hong Kong
- Agency: WILSON SONSINI GOODRICH & ROSATI
- Priority: WO TCN2021127023 2021.10.28 WO TCN2022112270 2022.08.12
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
Abstract:
Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
Public/Granted literature
- US20240002406A1 PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF Public/Granted day:2024-01-04
Information query
